Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $10.3350 (5.24%) ($10.3350 - $10.3350) on Wed. Dec. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.11% (three month average) | RSI | 49 | Latest Price | $10.3350(5.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(79%) IBB(77%) ARKK(72%) IWO(72%) IWM(69%) | Factors Impacting EDIT price | EDIT will decline at least -2.555% in a week (0% probabilities). EDOC(-30%) TBT(-26%) VXX(-25%) BNDX(-22%) VIXM(-17%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.555% (StdDev 5.11%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $10.38 | 5 Day Moving Average | $10.29(0.44%) | 10 Day Moving Average | $10.56(-2.13%) | 20 Day Moving Average | $10.38(-0.43%) | To recent high | -6.8% | To recent low | 65.1% | Market Cap | $642m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |